• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Journal of the Egyptian Society of Parasitology
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 50 (2020)
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 49 (2019)
Volume Volume 48 (2018)
Volume Volume 47 (2017)
Volume Volume 46 (2016)
Volume Volume 45 (2015)
Volume Volume 44 (2014)
Volume Volume 43 (2013)
AL-GHANDOUR, A., YOUSEF, A., MOHAMED, R., TEALEB, A., AHMED, H., ATWA, H., FARAG, T. (2020). PROPHYLACTIC ANTICRYPTOSPORIDIAL ACTIVITY OF ATORVASTATIN VERSUS NITAZOXANIDE ON EXPERIMENTALLY INFECTED IMMUNOSUPPRESSED MURINE MODELS. Journal of the Egyptian Society of Parasitology, 50(3), 535-546. doi: 10.12816/jesp.2020.131084
ASMAA M. FAROUK AL-GHANDOUR; ASMAA MOHAMMED YOUSEF; RASHA M. S. M. MOHAMED; AL-SAYED M. TEALEB; HYTHAM K. AHMED; HANAA A. ATWA; TAHANI ISMAIL FARAG. "PROPHYLACTIC ANTICRYPTOSPORIDIAL ACTIVITY OF ATORVASTATIN VERSUS NITAZOXANIDE ON EXPERIMENTALLY INFECTED IMMUNOSUPPRESSED MURINE MODELS". Journal of the Egyptian Society of Parasitology, 50, 3, 2020, 535-546. doi: 10.12816/jesp.2020.131084
AL-GHANDOUR, A., YOUSEF, A., MOHAMED, R., TEALEB, A., AHMED, H., ATWA, H., FARAG, T. (2020). 'PROPHYLACTIC ANTICRYPTOSPORIDIAL ACTIVITY OF ATORVASTATIN VERSUS NITAZOXANIDE ON EXPERIMENTALLY INFECTED IMMUNOSUPPRESSED MURINE MODELS', Journal of the Egyptian Society of Parasitology, 50(3), pp. 535-546. doi: 10.12816/jesp.2020.131084
AL-GHANDOUR, A., YOUSEF, A., MOHAMED, R., TEALEB, A., AHMED, H., ATWA, H., FARAG, T. PROPHYLACTIC ANTICRYPTOSPORIDIAL ACTIVITY OF ATORVASTATIN VERSUS NITAZOXANIDE ON EXPERIMENTALLY INFECTED IMMUNOSUPPRESSED MURINE MODELS. Journal of the Egyptian Society of Parasitology, 2020; 50(3): 535-546. doi: 10.12816/jesp.2020.131084

PROPHYLACTIC ANTICRYPTOSPORIDIAL ACTIVITY OF ATORVASTATIN VERSUS NITAZOXANIDE ON EXPERIMENTALLY INFECTED IMMUNOSUPPRESSED MURINE MODELS

Article 9, Volume 50, Issue 3, Autumn 2020, Page 535-546  XML PDF (1.43 MB)
Document Type: Original Article
DOI: 10.12816/jesp.2020.131084
Authors
ASMAA M. FAROUK AL-GHANDOUR1; ASMAA MOHAMMED YOUSEF1; RASHA M. S. M. MOHAMED2; AL-SAYED M. TEALEB3; HYTHAM K. AHMED4; HANAA A. ATWA5; TAHANI ISMAIL FARAG6
1Departments of Medical Parasitology
2Clinical Pharmacology
3Department of Pathology
4Clinical Pathology
5Pathology
6Departments of Medical Parasitology1
Abstract
This study investigated the possible prophylactic and curative role of Atorvastatin (ATV) in
treatment of cryptosporidiosis in immunosuppressed cases. Immunosuppression was done using
oral dexamethasone (0.25μg/g/day) for 14 days before infection till last scarification. The
study included 150 immunosuppressed mice in 5 major groups (N=30): G1: Normal control
group, G2: Infected control group, G3: ATV (40mg/kg/day), G4: Nitazoxanide (NTZ; 500-
mg/kg/day), G5: combination group. Each one was divided into 3 subgroups of 10 mice each:
prophylaxis ones received drug daily for 5 consecutive days before infection only, 1st and 2nd
therapeutic dose groups: mice received the drug for 1 week and 2 weeks after prophylaxis and
infection, respectively. Assessment was done parasitological by formol-ether concentration
and Modified Ziehl-Neelsen staining of stool pellets gathered weekly, immunological by serum
IFN-ɣ levels and histopathological by haematoxyline and eosin staining to determine the
drug regimens and parasite impacts on tissues.
The results showed a significant reduction in inflammatory changes of ileum, stomach and
liver histopathology and in oocysts shed on the 7th day post infection (PI) by 62.08%, 40.55%
& 71.78%, on the 14th day (PI) by 78.53%, 53.4%, 87.43% & 90.41%, 57.21%, 94.71% on
21st day (PI) in all treated groups respectively, compared to infected untreated control ones.
Sera IFN-ɣ levels showed significant increase in combination followed by ATV prophylactic
drug regimens compared to NTZ alone or infected control ones. Combined ATV and NTZ
prophylaxis gave a good synergistic anticryptosporidial efficacy in immunosuppressed mice.
Keywords
Cryptosporidium; Atorvastatin; Prophylaxis; Nitazoxanide combination; immunosuppressed
Statistics
Article View: 3
PDF Download: 14
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.